Home › Funds › DUMAC, INC. › SGMT
DUMAC, INC. position in SGMT
SAGIMET BIOSCIENCES INC COM SER A · Health Care
DUMAC, INC. reported holding 71,192 shares of SGMT (SAGIMET BIOSCIENCES INC COM SER A) in its Q2 2026 13F filing — a position valued at US$550K, representing 0.05% of its reported portfolio and ranking #14 among its reported holdings. DUMAC, INC. has disclosed SGMT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DUMAC, INC.'s SGMT position evolved
DUMAC, INC. first disclosed a stake in SGMT in Q3 2023 at 204,123 shares (US$1.8M). Across 10 filings, DUMAC, INC. increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 71,192 shares valued at US$550K. Notable position changes include a 49% trim in Q2 2025 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 204.12K | $1.80M | New |
| Q4 2023 | 204.12K | $1.11M | Hold |
| Q1 2024 | 189.39K | $1.03M | Reduce |
| Q3 2024 | 189.39K | $524.62K | Hold |
| Q4 2024 | 163.51K | $735.81K | Reduce |
| Q1 2025 | 147.35K | $480.36K | Reduce |
| Q2 2025 | 75.00K | $571.50K | Reduce |
| Q4 2025 | 71.19K | $421.46K | Reduce |
| Q1 2026 | 71.19K | $371.98K | Hold |
| Q2 2026 | 71.19K | $550.31K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SGMT and 13F data
SGMT (SAGIMET BIOSCIENCES INC COM SER A) is a Health Care company. 59 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$22.6M), BVF INC/IL (US$19.3M), Caligan Partners LP (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGMT
- SILVERARC CAPITAL MANAGEMENT, LLC 2.93M sh · $22.63M · Q2 2026
- BVF INC/IL 2.50M sh · $19.32M · Q2 2026
- Caligan Partners LP 2.50M sh · $19.32M · Q2 2026
- Affinity Asset Advisors, LLC 2.50M sh · $19.31M · Q2 2026
- GREAT POINT PARTNERS LLC 2.03M sh · $15.69M · Q2 2026
- Saturn V Capital Management LP 1.48M sh · $11.44M · Q2 2026
- Blue Owl Capital Holdings LP 1.26M sh · $9.74M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Seven Fleet Capital Management LP 403.55K sh · $3.12M · Q2 2026
- Palo Alto Investors LP 250.00K sh · $1.93M · Q2 2026
- Pale Fire Capital SE 221.88K sh · $1.72M · Q2 2026
- Sofinnova Investments, Inc. 166.67K sh · $1.29M · Q2 2026
FAQ
How long has DUMAC, INC. held SGMT?
DUMAC, INC. has disclosed SGMT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is DUMAC, INC.'s current position in SGMT?
As of Q2 2026, DUMAC, INC. holds 71.19K shares of SGMT (SAGIMET BIOSCIENCES INC COM SER A), valued at $550.31K, representing 0.05% of its reported portfolio and ranking #14.
Has DUMAC, INC. been buying or selling SGMT?
In the latest 13F filing (Q2 2026), DUMAC, INC. held unchanged its position in SGMT.
Which other funds hold SGMT?
Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.